Miyako Matsuo

1.8k citations

32 papers · 1.3k indexed · h-index 18

Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management 11
Cardiology and Cardiovascular Medicine top 2%
- Atrial Fibrillation Management and Outcomes 4
Hematology top 5%
- Blood Coagulation and Thrombosis Mechanisms 12
- Hemophilia Treatment and Research 8
- Platelet Disorders and Treatments 7
Nephrology top 5%
Emergency Medicine top 5%
- Intramuscular injections and effects 6
Surgery
- Heparin-Induced Thrombocytopenia and Thrombosis 13
Pulmonary and Respiratory Medicine
- Blood properties and coagulation 4

Co-authors: Takefumi Matsuo Kazuomi Kario Hiroko Kobayashi Kazuyuki Shimada Shunji Suzuki Masanobu Koide Toshiyuki Sakata Toshiyuki Miyata
Cited by: Internal Medicine Cardiology and Cardiovascular Medicine Hematology
Journals: Hypertension (1 paper)Arteriosclerosis Thrombosis and Vascular Biology (3 papers)American Journal of Kidney Diseases (1 paper)
Partner nations: Japan United States

In The Last Decade

Miyako Matsuo

32 papers receiving 1.3k citations

Peers

Countries citing papers authored by Miyako Matsuo

Since Specialization

Citations

This map shows the geographic impact of Miyako Matsuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miyako Matsuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miyako Matsuo more than expected).

Fields of papers citing papers by Miyako Matsuo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miyako Matsuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miyako Matsuo. The network helps show where Miyako Matsuo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Miyako Matsuo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Miyako Matsuo Line = papers co-authored together Miyako Matsuo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Anti-Heparin/PF4 Complexes by ELISA in Patients with Disseminated Intravascular Coagulation Pathophysiology of Haemostasis and Thrombosis ·Takefumi Matsuo,Miyako Matsuo,Takaki Sugimoto,Keiko Wanaka	2007	5
2	Frequency of Anti-Heparin-PF4 Complex Antibodies (HIT Antibodies) in Uremic Patients on Chronic Intermittent Hemodialysis Pathophysiology of Haemostasis and Thrombosis ·Takefumi Matsuo,Hiroko Kobayashi,Miyako Matsuo,Keiko Wanaka,Hidetomo Nakamoto,Hiroyuki Matsushima,Rumi Sakai	2006	22
3	Preexisting Antibodies to Platelet Factor 4-Heparin Complexes in Patients with Acute Coronary Syndrome Who Have No History of Heparin Exposure Pathophysiology of Haemostasis and Thrombosis ·Takefumi Matsuo,Shunji Suzuki,Miyako Matsuo,Hiroko Kobayasi	2005	16
4	Thrombotic Complications in Three Hemodialysis Patients With Heparin-Induced Thrombocytopenia Type I Clinical and Applied Thrombosis/Hemostasis ·Shunji Suzuki,Susumu Sakamoto,Miyako Matsuo,Chikako Shimano,Tatsumi Kuroda,Takefumi Matsuo	2004	3
5	Acute Myocardial Infarction Caused by Delayed Heparin-Induced Thrombocytopenia and Acute Immunoreaction due to Re-exposure to Heparin in a Systemic Lupus Erythematosus Patient with HIT Antibodies Clinical and Applied Thrombosis/Hemostasis ·Shunji Suzuki,Susumu Sakamoto,Takeaki Okada,Miyako Matsuo,Atsushi Saitoh,Takefumi Matsuo	2003	3
6	Combined treatment with nafamostat mesilate and aspirin prevents heparin-induced thrombocytopenia in a hemodialysis patient Clinical Nephrology ·Hideaki Takahashi,Shigeaki Muto,Eiko Nakazawa,Satoru Yanagiba,Y. Masunaga,Yoshihiro Miyata,Kaichirou Tamba,Eiji Kusano,Miyako Matsuo,Takefumi Matsuo,Yoshihide Asano	2003	15
7	Characteristics of Heparin-Induced Platelet Aggregates in Chronic Hemodialysis with Long-Term Heparin Use Pathophysiology of Haemostasis and Thrombosis ·Takefumi Matsuo,Miyako Matsuo,Kazuomi Kario,Shunji Suzuki	2000	6
8	The 27-bp repeat polymorphism in intron 4 of the endothelial cell nitric oxide synthase gene and ischemic stroke in a Japanese population Blood Coagulation & Fibrinolysis ·Yoshitsugu Yahashi,Kazuomi Kario,Kenichi Shimada,Miyako Matsuo	1998	43
9	Extrinsic Coagulation Factors and Tissue Factor Pathway Inhibitor in End-Stage Chronic Renal Failure Pathophysiology of Haemostasis and Thrombosis ·Takefumi Matsuo,Masanobu Koide,Kazuomi Kario,Shunji Suzuki,Miyako Matsuo	1997	34
10	Early onset of immunological heparin-induced thrombocytopenia in acute myocardial infarction Blood Coagulation & Fibrinolysis ·Shunji Suzuki,Masahiro Koide,Susumu Sakamoto,Shogo Yamamoto,Miyako Matsuo,Emi Fujii,Takefumi Matsuo	1997	10
11	Effective Anticoagulation by Argatroban During Coronary Stent Implantation in a Patient with Heparin-Induced Thrombocytopenia Thrombosis Research ·Shunji Suzuki,Susumu Sakamoto,Masanobu Koide,Miyako Matsuo,Katsura Fujii,T. Matsuo	1997	6
12	Heparin-induced thrombocytopenia in hemodialysis patients American Journal of Kidney Diseases ·Satomi Yamamoto,Masanobu Koide,Miyako Matsuo,Shunji Suzuki,M Ohtaka,Satoshi Saika,Takefumi Matsuo	1996	126
13	Effective anticoagulation by argatroban during immunoadsorption therapy for malignant rheumatoid arthritis with a high polymorphonuclear leukocyte elastase level Thrombosis Research ·Shunji Suzuki,Susumu Sakamoto,Masanobu Koide,Hiroko Kobayashi,Miyako Matsuo,Chikako Shimano,Takefumi Matsuo	1995	5
14	High Lipoprotein (a) Levels in Chronic Hemodialysis Patients are Closely Related to the Acute Phase Reaction Thrombosis and Haemostasis ·Kazuomi Kario,Takefumi Matsuo,Hiroko Kobayashi,Miyako Matsuo,Reiko Asada,Masanobu Koide	1995	50
15	Rapid quantitative evaluation of plasma D-dimer levels in thrombotic states using an automated latex photometric immunoassay Thrombosis Research ·Kazuomi Kario,Takefumi Matsuo,Hiroko Kabayashi,Miyako Matsuo,Katsuichirou Yamamoto,George Sakurai,Mituhiro Baba	1992	17
16	Congenital protein c deficiency and myocardial infarction: Concomitant factor VII hyperactivity may play a role in the onset of arterial thrombosis Thrombosis Research ·Kazuomi Kario,Takefumi Matsuo,Shigeru Tai,Susumu Sakamoto,Tsutomu Yamada,Takahiko Miki,Miyako Matsuo	1992	19
17	Imbalance between Thrombin and Plasmin Activity in Disseminated Intravascular Coagulation Pathophysiology of Haemostasis and Thrombosis ·Kazuomi Kario,Takefumi Matsuo,Kazuya Kodama,Miyako Matsuo,Katsuichirou Yamamoto,Hiroko Kobayashi	1992	26
18	Prophylactic antithrombin III administration during pregnancy immediately reduces the thrombin hyperactivity of congenital antithrombin III deficiency by forming thrombin-antithrombin III complexes Thrombosis Research ·Kazuomi Kario,Takefumi Matsuo,Kazuya Kodama,Miyako Matsuo	1992	10
19	Factor VII hyperactivity in chronic dialysis patients Thrombosis Research ·Kazuomi Kario,Takefumi Matsuo,Tsutomu Yamada,Kazukiyo Nakao,Chikako Shimano,Miyako Matsuo	1992	20
20	The transient increase of plasma thrombin-antithrombin III (TAT) complex levels in patients with congenital antithrombin III deficiency during antithrombin III administration is due to extraction of thrombin from fibrin Thrombosis Research ·Kazuomi Kario,Takefumi Matsuo,Hiroko Kabayashi,Miyako Matsuo,Katsuichirou Yamamoto	1991	3

About Miyako Matsuo

Miyako Matsuo is a scholar working on Internal Medicine, Hematology and Emergency Medicine, having authored 32 papers that have together received 1.3k indexed citations. Recurring topics across this work include Heparin-Induced Thrombocytopenia and Thrombosis (13 papers), Blood Coagulation and Thrombosis Mechanisms (12 papers), Venous Thromboembolism Diagnosis and Management (11 papers), Hemophilia Treatment and Research (8 papers), Platelet Disorders and Treatments (7 papers), Intramuscular injections and effects (6 papers), Blood properties and coagulation (4 papers) and Atrial Fibrillation Management and Outcomes (4 papers). The work is most often cited by research in Internal Medicine (263 citations), Cardiology and Cardiovascular Medicine (716 citations) and Hematology (293 citations). Miyako Matsuo has collaborated with scholars based in Japan and United States. Frequent co-authors include Takefumi Matsuo, Kazuomi Kario, Hiroko Kobayashi, Kazuyuki Shimada, Hiroko Kobayashi, Shunji Suzuki, Masanobu Koide, Toshiyuki Sakata, Toshiyuki Miyata and Tsutomu Yamada. Their work appears in journals such as Hypertension, Arteriosclerosis Thrombosis and Vascular Biology and American Journal of Kidney Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact